Gemmotherapy from Latin word “gemma”, means bud, and “justo” which means therapy. The name Gemmotherapy is not appropriate since it only refers to “buds” and that this therapy we use many other parts of the plant beyond the exclusive use of buds. If this was the case the use of buds only, then it would make sense to call it Gemmotherapy. Medicinal Embryonic Phytotherapy (MEPTM) uses only fresh embryonic plant tissues in their infancy stage of growth: buds of leaves, buds of flowers, young shoots, embryonic fruits, embryonic roots, germinating seeds, and internal bark.
Embryonic concentrated plant extracts were first investigated in the late 1950s by a Belgian physician, Pol Henry MD (1918-88), he called it “Phytoembryotherapy” and began working with a group of French homeopaths and biotherapists including Max Tétau MD (1927-) and O.A. Julian MD. It was renamed “Gemmotherapy” by Max Tétau.
Pol Henry, our founder, never used the 1DH diluted form. The embryonic tissues contain all the genetic informative chemistry of the future adult plant in its developing stage of growth. They contain all of the potential biological activities and energy, which is the anabolic ability from embryonic plant extracts.
These embryonic plant extracts have very specific therapeutic targets at the cellular detoxification level and thereby regain normal organ function (homeostasis), and the regulation of apoptosis and other biological activities that are quite literally, too numerous to list them all. Reliable and dependable results can be achieved with embryonic plant extracts as a standalone Biotherapeutic program, and expected by the use of these embryonic plant extracts. Results will exceed those of adult phytotherapy due to the fact that adult phytotherapy produces inconsistent results.
In 1975 a French eclectic medical phytotherapist Dominique Richard, affiliated with Dolisos laboratories USA, was first to introduce this Biotherapy in the United States. Dominique Richard was trained in part by Dr. Max Tétau and, in time, was a mentor to him. He spent thirty five years researching embryonic phytotherapy documenting blood tests of individuals (before and after) to explain scientifically their biological therapeutic activities. He also identified many new phytohormones, phytochemicals and made many new discoveries and indications regarding their applications. His research is being published in the Medicinal Embryonic Phytotherapy Encyclopedia. It will be a text book of reference to designing a custom biotherapeutic program. The book is due out in 2016.